Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation
Alison M. Weppler, Laetitia Da Meda, Inês Pires da Silva, Wen Xu, Giovanni Grignani, Alexander M. Menzies, Matteo S. Carlino, Georgina V. Long, Serigne Lo, Ina Nordman, Christopher Steer, Megan Lyle, Claudia Trojaniello, Paolo A. Ascierto, Célèste Lebbé, Shahneen Sandhu (2023). Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation. , 183, DOI: https://doi.org/10.1016/j.ejca.2023.01.016.
Article230 days agoFDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma
Li Zhou, Milton Barros, Edward Hsiao, Zeynep Eroglu, Shahneen Sandhu, Igor Samoylenko, Serigne Lo, Matteo S Carlino, George Au‐Yeung, Maria Gonzalez, Andrew J. Spillane, Thomas E Pennington, Kerwin F Shannon, Rony Kapoor, Elizabeth M. Burton, Hussein A. Tawbi, Rodabe N. Amaria, Christian U. Blank, João Pedreira Duprat Neto, Rafaela Brito de Paula, David E Gyorki, R.P.M. Saw, Sydney Ch'ng, Robert V. Rawson, Richard A. Scolyer, Inês Pires da Silva, Alexander C J van Akkooi, Georgina V Long, Alexander M. Menzies (2025). FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma. , 13(3), DOI: https://doi.org/10.1136/jitc-2025-011483.
Article230 days agoThe role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
Michielin Olivier, Reinhard Dummer, Paul Lorigan, Dirk Schadendorf, Georgina V. Long, Ester Simeone, Paolo A. Ascierto, Domenico Mallardo, Rachel Woodford, Alexander M. Menzies, Lisa Zimmer, A. P. Williamson, Egle Ramelyte, Florentia Dimitriou, Alexandre Wicky, Roslyn Wallace, Mario Mallardo, Alessio Cortellini, Alfredo Budillon, Victoria Atkinson, Shahneen Sandhu (2023). The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab. , 21(1), DOI: https://doi.org/10.1186/s12967-023-04607-4.
Article230 days agoEfficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia
Samuel Cass, Joshua W.D. Tobin, Yongwoo David Seo, Georgina Gener‐Ricos, Emily Z. Keung, Elizabeth M. Burton, Michael A. Davies, Jennifer L. McQuade, Alexander J. Lazar, Robert M. Mason, Michael Millward, Shahneen Sandhu, Chloe Khoo, Lydia Warburton, Veronica Guerra, Andrew Haydon, Helen Dearden, Alexander M. Menzies, Matteo S. Carlino, Jessica L. Smith, Peter Mollee, Melinda Burgess, Sally Mapp, Colm Keane, Victoria Atkinson, Sameer A. Parikh, Svetomir N. Markovic, Wei Ding, Timothy G. Call, Paul J. Hampel, Georgina V. Long, Jennifer A. Wargo, Alessandra Ferrajoli (2023). Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia. , 34(9), DOI: https://doi.org/10.1016/j.annonc.2023.06.007.
Article230 days agoNeoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in macroscopic, resectable stage III melanoma: The phase 3 NADINA trial.
Christian U. Blank, Minke W. Lucas, Richard A. Scolyer, Bart A. van de Wiel, Alexander M. Menzies, Marta López‐Yurda, Alexander Christopher Jonathan Van Akkooi, Winan J. van Houdt, Robyn P.M. Saw, Alex Torres Acosta, Serigne Lo, Geke A.P. Hospers, Matteo S. Carlino, Jan Willem de Groot, Ellen Kapiteijn, Karijn P.M. Suijkerbuijk, Piotr Rutkowski, Shahneen Sandhu, Astrid Aplonia Maria Van Der Veldt, Georgina V. Long (2024). Neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in macroscopic, resectable stage III melanoma: The phase 3 NADINA trial.. , 42(17_suppl), DOI: https://doi.org/10.1200/jco.2024.42.17_suppl.lba2.
Article230 days ago